Beryl Capital Management LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Revance Therapeutics, Inc. Common Stock (RVNC)

Filing Manager
Beryl Capital Management LLC
Reporting Manager
Beryl Capital Management LLC
Security
Revance Therapeutics, Inc. Common Stock
Symbol
RVNC
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 12:33:26 UTC
Date of event
31 Mar 2025
Previous filing
10 Jan 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Beryl Capital Management LLC 0% 0 0 0 /s/ Andrew Nelson Chief Operating Officer
Beryl Capital Management LP 0% 0 0 0 /s/ Andrew Nelson Chief Operating Officer of Beryl Capital Management LLC, General Partner of Beryl Capital Management LP
Beryl Capital Partners II LP 0% 0 0 0 /s/ Andrew Nelson COO of Beryl Capital Management LLC, General Partner of Beryl Capital Management LP, General Partner of Beryl Capital Partners II LP
David A. Witkin 0% 0 0 0 /s/ David A. Witkin Reporting person